This article is part of the HPV Gap series, where editors at KYN report on HPV from every side: what it is, why it spreads, who gets left out of the conversation, and what happens to them.


On May 6th, 2026, Korea announced that they would begin offering free HPV vaccination to 12-year-old boys born in 2014. The policy, according to the Korea Disease Control and Prevention Agency, was closing a gap of HPV vaccination between the two sexes. Nearly nine out of ten South Korean teenage girls have received at least one dose of the HPV vaccine. For boys, the number remains below one percent. The new program extends a national immunization scheme that already covered girls aged 12–17 and low-income women aged 18–26, while everyone else paid out of pocket, and it will grow with each birth year: boys born in 2015 become newly eligible in 2027, and so on. Officials have described the goal as reducing the long-term burden of HPV-related cancers in both sexes.


Male vaccination rates, which the policy was meant to fix, however, was never really about money. Male vaccination for HPV was excluded from the national immunization program for years, and that exclusion — not the price tag alone — produced low awareness among parents of sons. A subsidy, like the one offered by the recently announced program, changes what a vaccine costs. It does not, on its own, change what a parent believes about whether their son needs it. Because adolescent vaccination in Korea is driven overwhelmingly by parents rather than by adolescents' own decision-making, whether parents deem the vaccine essential is the actual variable male vaccination depends on. A 12-year-old, for example, does not book his own appointment. He does not weigh the research. His mother or father does, on his behalf, often based on whatever they happen to already know, from what their generation learned.


Sungsu Kim, an associate professor in the School of Media and Advertising at Kookmin University, argues that Korea's public health messaging has been aimed at the wrong audience. “Family-based education and discussion matter for uptake,” he said. Existing campaigns, he added, have concentrated on a single message that HPV vaccination is necessary, pitched as though the adolescent were the one being persuaded. 


What Korea lacks, however, is a second and more specific message: that parents themselves are the ones deciding, and that they are the ones who need to be equipped for it. He is skeptical that formal, sex-education-adjacent instruction could realistically happen at the family level, given the country's cultural discomfort with the subject, and pointed instead to online resources and tools like AI chatbots as more realistic channels for informing parents directly.


Hye-Sun Lee, a research professor at Hallym University's School of Digital Content Convergence, located a second failure point: not before the decision, but at the moment a child asks about it. Schools and families, she said, need to be able to give an adolescent an appropriate, substantive answer when he asks why he needs to get a shot in his arm. That moment, she said, is often handled poorly: parents hesitant even to say the word HPV, or falling back on non-answers like "because I'm told that you have to" or "because you're in the target group." 


A parent who cannot explain the vaccine may not be able to explain to a hesitant son why he should get vaccinated in the first place — and research on HPV vaccination broadly bears this out, finding that parental knowledge and beliefs are direct predictors of whether an adolescent ends up vaccinated.


This is evident with Eunjeong Kim, a 47-year-old parent of a teenage son. For her, cost was never a factor in her reluctance to vaccinate. Kim was aware that the policy about HPV vaccination had changed in favor of boys, but what she'd absorbed about HPV stopped at the vague sense that it "could affect boys,” noting nothing about how or why it mattered for her son specifically. She had never been offered, or sought out, any family-based education on the subject. That absence shows up directly in her reasoning: "Is vaccination really necessary? Why would he need it?" she asked. "There have been so many strange complications linked to vaccines since COVID. Why bother with this one?" The free vaccine hasn't changed her answer. Her son, she said, has gone this long without it and hasn't had any issues, so unless it becomes truly necessary, she'd rather leave it alone.


What the parent’s reasoning shows is not a parent weighing HPV specifically and deciding against it. It's a parent who was never given anything specific to weigh, filling that vacuum with a general wariness of vaccines that has nothing to do with HPV in particular. Meanwhile, her son isn't being asked whether he wants the vaccine. She is. And the answer she's giving isn't really about her son's risk; it's about a subsidy that removed one barrier while leaving the one underneath it untouched. The government solved the cost. The government solved the cost. It did nothing for a mother who still can't see the reason.